Cttq clinical trials

Acquired by Sino Biopharmaceutical Limited

The registry lists 9 studies whose lead sponsor is Cttq. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 7, 2021.

Studies

Recruiting first, then most recently updated. Showing 9 of 9. All Sino Biopharmaceutical Limited studies →

• Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using CaspofunginCompletedNCT03857399Phase 2

  Sponsor listed in the registry: Cttq · Cttq — acquired company within the Sino Biopharmaceutical Limited group

• Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes ZosterCompletedNCT02151240Phase 4

  Sponsor listed in the registry: Cttq · Cttq — acquired company within the Sino Biopharmaceutical Limited group

• Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter TrialStatus unknownNCT04106024Phase 2

  Sponsor listed in the registry: Cttq · Cttq — acquired company within the Sino Biopharmaceutical Limited group

• Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis BStatus unknownNCT03349008Phase 4

  Sponsor listed in the registry: Cttq · Cttq — acquired company within the Sino Biopharmaceutical Limited group

• Generic Zoledronic Acid Versus Original Zoledronic Acid in Postmenopausal Osteoporotic WomenStatus unknownNCT03158246Phase 4

  Sponsor listed in the registry: Cttq · Cttq — acquired company within the Sino Biopharmaceutical Limited group

• Intensive Medicines Monitoring Project of Palonosetron Hydrochloride Capsules (Ruo Shan®)Status unknownNCT03148704

  Sponsor listed in the registry: Cttq · Cttq — acquired company within the Sino Biopharmaceutical Limited group

• Efficacy and Safety of Imatinib Mesylate as First-line Treatment for the Patients With Chronic Phase of Chronic Myeloid LeukemiaStatus unknownNCT02317159Phase 4

  Sponsor listed in the registry: Cttq · Cttq — acquired company within the Sino Biopharmaceutical Limited group

• A Phase Ⅳ Study of Decitabine in Myelodysplastic SyndromeStatus unknownNCT02013102Phase 4

  Sponsor listed in the registry: Cttq · Cttq — acquired company within the Sino Biopharmaceutical Limited group

• Evaluate the Efficacy of Magnesium Isoglycyrrhizinate in the Prevention of Chemotherapy Related Acute Liver InjuryStatus unknownNCT01802996Phase 4

  Sponsor listed in the registry: Cttq · Cttq — acquired company within the Sino Biopharmaceutical Limited group